Skip to Content Facebook Feature Image

Easmed and The Air Station unveil hidden sleep apnea risk across Singapore's workforce in landmark survey

Asia Pacific

Easmed and The Air Station unveil hidden sleep apnea risk across Singapore's workforce in landmark survey
Asia Pacific

Asia Pacific

Easmed and The Air Station unveil hidden sleep apnea risk across Singapore's workforce in landmark survey

2026-09-10 08:00 Last Updated At:08:16

Findings uncover a hidden sleep crisis driving daytime exhaustion and productivity loss despite a full night's rest

  • Almost the entire office workforce (97%) experiences performance drops following a bad night's sleep, with 58% losing over 20% of their daily output.
  • Most workers fail to recognise sleep apnea signs, misinterpreting chronic gasping, snoring, and daytime exhaustion as standard work stress.

SINGAPORE – Media OutReach Newswire – 10 September 2026 – A comprehensive sleep health survey titled, "Sleeping Enough, Waking Up Tired: The Hidden Cost of Sleep Apnea Risk in Singapore's Workforce", reveals that unaddressed sleep disorders are quietly eroding productivity across the nation's workforce.

The survey is jointly commissioned by Easmed and The Air Station, Singapore-headquartered medical technology companies specialising in innovative medical devices and sleep health solutions. The survey of 1,000 office-based working adults in Singapore aged 30 to 60, conducted in June 2026, reveals a concerning gap between sleep debt, clinical risk and public awareness.

Sleep Apnea is a prevalent medical condition where the upper airway repeatedly relaxes and collapses during sleep, temporarily cutting off oxygen flow. This forces the brain to repeatedly wake the body up to restart breathing, disrupting core sleep cycles and causing loud snoring, gasping, and severe daytime exhaustion.

Key Survey Highlights

  • Workplace productivity drain: 97% of respondents experience a productivity drop after a poor night's sleep, with 58% estimating their performance drops by more than 20%.
  • Hidden clinical risk: 1 in 4 (24%) office workers screen at intermediate-to-high risk for Sleep Apnea.
  • Widespread awareness gap: 60% of employees have never heard of Sleep Apnea or only know the name. Additionally, 56% have never evaluated their sleep quality via a doctor, app, or diagnostic test.
  • Nightly sleep deficit: Singapore workers average 6.3 hours of sleep per night compared to the 7.4 hours they need to feel refreshed, leaving a daily 1.1-hour shortfall.
  • Normalised misconceptions: 50% view daytime fatigue as a normal part of busy working life, 25% believe brief breathing pauses during sleep are harmless, and 24% mistake loud snoring for deep sleep.
  • Key hurdles to care: Cost of diagnosis/treatment (51%) and lack of knowledge on where to seek help (36%) are the primary reasons workers avoid getting evaluated for Sleep Apnea.

While 72% of employees cite flexible hours as their top ask for sleep support, health experts emphasise that extra time in bed cannot fix underlying physiological conditions like Sleep Apnea.

Corporate access to subsidised screening (37%) and targeted sleep education (21%) remain the most direct solutions.

Commenting on the survey findings, Dr Phua Chu Qin, Senior Consultant Otolaryngology (ENT) and Director of Sleep Surgery at Sengkang General Hospital, said: "The productivity findings for this local survey reinforce that sleep is not simply a lifestyle issue. This is timely, because Singaporeans need to move away from normalising poor sleep and persistent daytime fatigue and start to recognise when poor sleep warrants assessment."

"Snoring and witnessing breathing pauses during sleep should not automatically be dismissed as harmless. Recognising these warning signs early and getting assessed can be an important step towards better health, alertness and productivity," she added.

The sleep paradox: Time in bed versus restorative sleep
The study highlighted a striking disconnect between time spent in bed and actual sleep quality. On average, Singapore office workers accumulate a nightly "sleep debt" of 1.1 hours, getting 6.3 hours of sleep against a reported need of 7.4 hours.

However, individuals screening at the highest risk for Sleep Apnea actually reported longer average bedtimes (6.68 hours) than low-risk workers (6.30 hours). Because Sleep Apnea causes repeated airway collapses and micro-awakenings throughout the night, time spent in bed fails to translate into restorative sleep.

The desensitisation runs deeper: high-risk workers were more than twice as likely as low-risk workers to say a poor night's sleep had "no impact" on their productivity (8% vs. 2.5%), and significantly more likely to say poor sleep hadn't affected their concentration at all. Thus, the group carrying the greatest health risk is also the group least able to recognise it in themselves, underscoring why self-assessment alone cannot catch Sleep Apnea, and why objective clinical screening is essential.

Dangerous myths keep Singaporeans in the dark
The report uncovered prevalent misconceptions regarding sleep hygiene and clinical signs, that may be delaying diagnosis:

  • 50% of respondents view daytime sleepiness as "just a normal part of a busy working life."
  • 25% believe brief pauses in breathing during sleep are harmless.
  • 24% believe loud, regular snoring is a sign of deep, healthy sleep.

Over 80% of the workforce recognises that sleep sacrifice isn't a virtue, yet nearly 1 in 5 still feel needing little sleep signals a strong work ethic.

Among individuals already sitting in the high-risk Sleep Apnea bracket, these myths run even deeper: 52% believe loud snoring is healthy and 54% view breathing interruptions as harmless, suggesting many high-risk individuals are unknowingly reassuring themselves out of seeking help.

A call for workplace sleep wellness
While 72% of employees indicated a desire for flexible working hours to manage sleep, health experts emphasise that schedule adjustments alone cannot solve clinical sleep disorders like Sleep Apnea. Instead, actionable support requires early detection and clinical intervention.

"Sleep health can no longer be viewed purely as a personal lifestyle choice; it is a critical workplace health issue that directly impacts safety, decision-making, and long-term cardiovascular health," said Yvonne Loo, Group Director at Easmed.

"Our goal in commissioning this survey is to lower the friction for screening. Structural barriers like clinical diagnostic costs (51%) and confusion on where to seek help (36%) can be easily solved through accessible home sleep testing and corporate wellness partnerships."

Explore more survey results here: www.easmed.com/sgsleepsurvey2026

About the survey
The "Sleeping Enough, Waking Up Tired: The Hidden Cost of Sleep Apnea Risk in Singapore's Workforce" survey was jointly commissioned by Easmed and The Air Station, bringing together two complementary perspectives in sleep health — medical innovation and clinical care on one hand, and consumer sleep wellness, screening and treatment support on the other. Read more about sleep health survey here: www.easmed.com/sgsleepsurvey2026

Hashtag: #WorkplaceWellness #SleepApnea #Easmed #TheAirStation




The issuer is solely responsible for the content of this announcement.

About Easmed

Easmed is a Singapore-headquartered medical technology company with a longstanding focus on advancing sleep medicine in Southeast Asia. Working closely with healthcare professionals and institutions, Easmed provides medical and surgical technologies across Sleep Medicine, ENT, Neuro and Urology.

In sleep medicine, Easmed focuses on advanced treatment solutions for Obstructive Sleep Apnea (OSA). Its portfolio includes Inspire®️ hypoglossal nerve stimulation, an implantable treatment option for appropriately selected OSA patients, reflecting the company's involvement across both established and emerging approaches to sleep apnea care.

Beyond medical technology, Easmed actively supports clinical research, education and public awareness of sleep health, working with sleep specialists and healthcare professionals to improve understanding of OSA, its health implications and the importance of earlier recognition and intervention.

The commissioning of the Singapore Sleep Health Report is an extension of this work — using local data to better understand how sleep and undiagnosed sleep disorders may be affecting Singapore's workforce and to encourage a broader conversation about sleep as an important pillar of health.

Follow Easmed on social media:
Instagram: Facebook: LinkedIn:

About The Air Station

The Air Station is a Singapore consumer-facing sleep health company providing an end-to-end pathway from better sleep and early screening to diagnosis, treatment and ongoing support.

Its services span across sleep wellness solutions, sleep health screening, home sleep studies and a range of treatment options for sleep apnea, including dental sleep appliances and CPAP therapy, the established first-line treatment for many patients with OSA.

The Air Station also works to take sleep health beyond the clinic. Through corporate sleep health talks, community education, screening initiatives and sleep wellness programmes, it aims to make sleep health easier for the public to understand and act upon.

Its approach recognises that poor sleep exists on a spectrum: for some, better sleep habits and wellness interventions may help; for others, persistent snoring, excessive daytime sleepiness or disrupted breathing may warrant screening and medical assessment.

Together, Easmed and The Air Station connect the clinical and consumer sides of sleep health — from medical innovation and healthcare professional education to public awareness, screening and practical pathways to care.

Their jointly commissioned study of 1,000 working adults in Singapore found that approximately 1 in 4 screened at intermediate-to-high risk of OSA, while 60% had either never heard of OSA or knew it only by name. The findings also highlighted the relationship between poor sleep and workplace performance, with 97% of respondents reporting some productivity decline following a bad night's sleep.

The organisations hope the findings will encourage employers, healthcare professionals and communities to look beyond simply asking "Are we sleeping enough?" and start asking "Are we sleeping well — and could an underlyin disorder be going unnoticed?"

Follow The Air Station on social media:
Instagram:Facebook:LinkedIn:Youtube:TikTok:

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **

HONG KONG SAR – Media OutReach Newswire – 7 November 2026 – Prof. Nancy IP, President and The Morningside Professor of Life Science at The Hong Kong University of Science and Technology (HKUST), has been awarded the 2026 UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences in recognition of her pioneering contributions to neuroscience and Alzheimer's disease research. The award ceremony was held on November 6 at UNESCO Headquarters in Paris, France.

Prof. Nancy Ip, President and Morningside Professor of Life Science at HKUST, has been awarded the 2026 UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences in recognition of her pioneering contributions to neuroscience and Alzheimer's disease research. Prof. Ip accepts the award at a ceremony held on November 6 at the UNESCO Headquarters in Paris, France.

Prof. Nancy Ip, President and Morningside Professor of Life Science at HKUST, has been awarded the 2026 UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences in recognition of her pioneering contributions to neuroscience and Alzheimer's disease research. Prof. Ip accepts the award at a ceremony held on November 6 at the UNESCO Headquarters in Paris, France.

In announcing the award, UNESCO recognized Prof. Ip as an internationally renowned neuroscientist whose research has significantly advanced the understanding of brain function and neurodegenerative diseases. It highlighted her team's discoveries of novel biomarkers and genetic risk factors for Alzheimer's disease, the development of an innovative blood-based diagnostic technology that enables earlier detection and monitoring of the disease, and her pioneering advances in gene therapy research that have opened new avenues for the prevention and treatment of neurodegenerative disorders.

Receiving the award in Paris, Prof. Ip expressed her heartfelt gratitude to her research team, collaborators and colleagues, and thanked HKUST for its steadfast support throughout her scientific journey.

Prof. Nancy Ip (middle) joins the 2026 UNESCO-Equatorial Guinea International Prize laureates and Fellowship Programme for Young Women Scientists in Africa recipients for a group photo.

Prof. Nancy Ip (middle) joins the 2026 UNESCO-Equatorial Guinea International Prize laureates and Fellowship Programme for Young Women Scientists in Africa recipients for a group photo.

Prof. Ip said: "I am deeply honored to receive the UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences. This recognition belongs not only to me, but also to the many talented and dedicated team members, collaborators and colleagues who have contributed to these achievements. It reflects our shared commitment to advancing knowledge, deepening our understanding of Alzheimer's disease, and translating scientific discoveries into meaningful benefits for patients and society."

She added: "Alzheimer's disease is not just a scientific and medical challenge. It is also a deeply human one, profoundly affecting the lives of those living with the disease and their families. Their courage reminds us why our work matters and inspires us to reach higher."

Prof. Ip also emphasized the importance of global scientific collaboration and nurturing future generations of researchers. "Science is a collective endeavor," she said. "Every breakthrough is built on collaboration across disciplines, institutions and borders. As a scientist and university president, I believe we must also empower young researchers by giving them the freedom to pursue their curiosity, the confidence to take intellectual risks, and the support they need to tackle the grand challenges facing humanity."

Prof. Nancy Ip expressed her heartfelt gratitude to her research team, collaborators and colleagues, and thanked HKUST for its steadfast support throughout her scientific journey.

Prof. Nancy Ip expressed her heartfelt gratitude to her research team, collaborators and colleagues, and thanked HKUST for its steadfast support throughout her scientific journey.

Breakthrough Contributions to Neuroscience and Alzheimer's Disease Research

Prof. Ip has devoted more than three decades to advancing research on neurodegenerative diseases. To date, she has published over 350 scholarly papers and holds 144 patents. Her pioneering work has significantly deepened scientific understanding of intercellular communication in the nervous system, synaptic signaling, and the molecular mechanisms underlying neurodegenerative diseases. Her research team has also achieved a series of breakthroughs in identifying protein targets associated with these disorders, opening new avenues for their diagnosis and treatment.

Recognizing that Alzheimer's disease research has historically relied heavily on data from Western populations, with Asian populations being relatively underrepresented, Prof. Ip led her team in establishing a large-scale Chinese Alzheimer's disease biobank. By integrating clinical data, neuroimaging information, and multi-omics datasets from Chinese populations, the team successfully identified multiple genetic risk factors prevalent among Chinese individuals. These findings have provided important scientific insights into disease mechanisms and laid a foundation for the development of precision diagnostic and therapeutic strategies.

In recent years, Prof. Ip and her team have made significant advances in the early detection of Alzheimer's disease and the clinical translation of related research. They co-developed a highly accurate, minimally invasive, and efficient blood-based diagnostic test that can aid early detection of Alzheimer's disease and help identify individuals with mild cognitive impairment, thereby supporting timely clinical assessment and intervention planning, as well as the identification of suitable participants for clinical trials. The technology has been adopted by multiple healthcare institutions in Hong Kong and has since been expanded into community settings, helping to inform more effective disease management and risk-reduction strategies. Meanwhile, the team is actively exploring novel gene therapy approaches for familial Alzheimer's disease through gene-editing technologies, with the goal of developing an integrated innovation pipeline spanning early diagnosis to next-generation therapeutics.

An Internationally Acclaimed Scientist

Prof. Ip is President of The Hong Kong University of Science and Technology (HKUST) and concurrently serves as Director of the State Key Laboratory of Nervous System Disorders and Director of the Hong Kong Center for Neurodegenerative Diseases. Prior to joining HKUST, she was a Senior Staff Scientist at Regeneron Pharmaceuticals in the United States. Since joining HKUST, she has held a number of key leadership positions, including Head of the Department of Biochemistry, Dean of Science, and Vice-President for Research and Development, before assuming the presidency of the University in 2022.

Renowned internationally for her scientific achievements and academic leadership, Prof. Ip is an elected member of the Chinese Academy of Sciences, the US National Academy of Sciences, the American Academy of Arts and Sciences, The World Academy of Sciences (TWAS), Academia Europaea, and the Hong Kong Academy of Sciences. Her many honors include the L'Oréal-UNESCO For Women in Science Award, the State Natural Science Award of China (twice), and recognition by Nature as one of China's "Ten Science Stars". She was also appointed Chevalier de l'Ordre National du Mérite by the French Government and awarded both the Silver Bauhinia Star and Bronze Bauhinia Star by the HKSAR Government.

The UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences was established by UNESCO to recognize outstanding scientific achievements that advance human health and improve quality of life. The Prize promotes scientific excellence, international collaboration, and the development of research networks worldwide. This year's prize is shared by three laureates, who jointly receive US$300,000 and an Integración Tribal statuette created by Equatorial Guinean artist Leandro Mbomio Nsue.

Hashtag: #HKUST

The issuer is solely responsible for the content of this announcement.

About The Hong Kong University of Science and Technology

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **

Recommended Articles